Skip to content

Mobile Health-based remote intervention trial for LARS patients

Remote management platform for patients with low anterior resection syndrome: protocol for a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061317
Enrollment
Unknown
Registered
2022-06-20
Start date
2022-07-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

intervention group:Based on the "e-intestinal safety" platform combined with motivational interview
control group:a information booklet that contains the same information as that provided in the informational module of platform as intervention group

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.>= 18 years old; 2. Patients undergo anal preservation surgery, and the malignant tumor is 15cm from the anal margin; 3. Survival is more than 1 year; 4. Patients or main caregivers use WeChat; 5. LARS>=21; 6. Clarify their condition and agree to participate in the investigation.

Exclusion criteria

Exclusion criteria: 1. Patients undergoing chemotherapy or other clinical experiments; 2. patients with other chronic intestinal diseases; 3. patients with previous or current mental disorders, consciousness disorders and communication disorders or patients who are unable to communicate in Chinese and English.

Design outcomes

Primary

MeasureTime frame
Global health-related quality of life;

Secondary

MeasureTime frame
Bowel function;Self management behavior;

Countries

China

Contacts

Public ContactShaohua Hu
hushaohua1003@126.com+86 13909696206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026